Involvement of Transcription Factor FoxO1 in the Pathogenesis of Polycystic Ovary Syndrome

Overview

Journal Front Physiol

Date 2021 Mar 22

PMID 33746783

Citations 12

Authors

Renfeng Xu

Zhengchao Wang

Affiliations

Soon will be listed here.

Abstract

FoxO1 is a member of the forkhead transcription factor family subgroup O (FoxO), which is expressed in many cell types, and participates in various pathophysiological processes, including cell proliferation, apoptosis, autophagy, metabolism, inflammatory response, cytokine expression, immune differentiation, and oxidative stress resistance. Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in the women of childbearing age, which is regulated a variety of signaling pathways. Currently, the specific mechanism underlying the pathogenesis of PCOS is still unclear. As an important transcription factor, FoxO1 activity might be involved in the pathophysiology of PCOS. PCOS has been associated with insulin resistance and low-grade inflammatory response. Therefore, the studies regarding the role of FoxO1 in the incidence and associated complications of PCOS will help provide novel ideas for establishing the treatment strategy of PCOS.

Citing Articles

miR-138-5p inhibits healing of femoral fracture osteogenesis in rats by modulating osteoblast differentiation via SIRT1/FOXO1 axis.

Dai G, Jiang W, Feng B, Zhang L J Orthop Surg Res. 2025; 20(1):280.

PMID: 40082921 PMC: 11907804. DOI: 10.1186/s13018-025-05667-6.

Polycystic Ovary Syndrome and Ferroptosis: Following Ariadne's Thread.

Geronikolou S, Pavlopoulou A, Koutelekos I, Kalogirou D, Bacopoulou F, Cokkinos D Biomedicines. 2024; 12(10).

PMID: 39457593 PMC: 11505293. DOI: 10.3390/biomedicines12102280.

Shared diagnostic genes and potential mechanisms between polycystic ovary syndrome and recurrent miscarriage revealed by integrated transcriptomics analysis and machine learning.

He J, Liu A, Shen H, Jiang Y, Gao M, Yu L Front Endocrinol (Lausanne). 2024; 15:1335106.

PMID: 39398336 PMC: 11466764. DOI: 10.3389/fendo.2024.1335106.

Exploring the Potential of Natural Products as FoxO1 Inhibitors: an Approach.

Gupta A, Haldhar R, Agarwal V, Rajput D, Chun K, Han S Biomol Ther (Seoul). 2024; 32(3):390-398.

PMID: 38586882 PMC: 11063485. DOI: 10.4062/biomolther.2023.156.

Diagnostic predictability of serum miR-4793-3p and miR-1180-3p expression in community-acquired pneumonia.

Chai R, Zhou C, Hu Z, Hu J Biomark Med. 2024; 18(6):231-241.

PMID: 38456294 PMC: 11216277. DOI: 10.2217/bmm-2023-0463.

References

Pandey A, Raj P, Goru S, Kadakol A, Malek V, Sharma N . Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacol Rep. 2017; 69(4):666-672. DOI: 10.1016/j.pharep.2017.02.005. View

Wang C, Ding C, Hua Z, Chen C, Yu J . Cangfudaotan Decoction Alleviates Insulin Resistance and Improves Follicular Development in Rats with Polycystic Ovary Syndrome via IGF-1-PI3K/Akt-Bax/Bcl-2 Pathway. Mediators Inflamm. 2020; 2020:8865647. PMC: 7707997. DOI: 10.1155/2020/8865647. View

Kamagate A, Dong H . FoxO1 integrates insulin signaling to VLDL production. Cell Cycle. 2008; 7(20):3162-70. PMC: 2664837. DOI: 10.4161/cc.7.20.6882. View

Gonzalez F, Rote N, Minium J, OLeary V, Kirwan J . Obese reproductive-age women exhibit a proatherogenic inflammatory response during hyperglycemia. Obesity (Silver Spring). 2007; 15(10):2436-44. PMC: 3000558. DOI: 10.1038/oby.2007.289. View

Ibfelt T, Fischer C, Plomgaard P, van Hall G, Pedersen B . The acute effects of low-dose TNF-α on glucose metabolism and β-cell function in humans. Mediators Inflamm. 2014; 2014:295478. PMC: 3945645. DOI: 10.1155/2014/295478. View

Wang F, Zhang Z, Xiao K, Wang Z . Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017; 39(5):699-704. DOI: 10.3881/j.issn.1000-503X.2017.05.017. View

Barthelmess E, Naz R . Polycystic ovary syndrome: current status and future perspective. Front Biosci (Elite Ed). 2014; 6(1):104-19. PMC: 4341818. DOI: 10.2741/e695. View

Simkova M, Vitku J, Kolatorova L, Vrbikova J, Vosatkova M, Vcelak J . Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?. Physiol Res. 2020; 69(Suppl 2):S279-S293. PMC: 8603732. DOI: 10.33549/physiolres.934521. View

Wang Z, Yu T, Huang P . Post-translational modifications of FOXO family proteins (Review). Mol Med Rep. 2016; 14(6):4931-4941. DOI: 10.3892/mmr.2016.5867. View

10.

Montanini L, Smerieri A, Gulli M, Cirillo F, Pisi G, Sartori C . miR-146a, miR-155, miR-370, and miR-708 Are CFTR-Dependent, Predicted FOXO1 Regulators and Change at Onset of CFRDs. J Clin Endocrinol Metab. 2016; 101(12):4955-4963. DOI: 10.1210/jc.2016-2431. View

11.

Vigil P, Contreras P, Alvarado J, Godoy A, Salgado A, Cortes M . Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Hum Reprod. 2007; 22(11):2974-80. DOI: 10.1093/humrep/dem302. View

12.

Escobar-Morreale H . Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab. 2012; 23(10):509-15. DOI: 10.1016/j.tem.2012.04.003. View

13.

Cirillo F, Catellani C, Sartori C, Lazzeroni P, Morini D, Nicoli A . and gene expression are reduced and high mobility group box 1 (HMGB1) is increased in the ovaries and serum of women with polycystic ovarian syndrome. Gynecol Endocrinol. 2019; 35(10):842-846. DOI: 10.1080/09513590.2019.1599349. View

14.

Genin E, Caron N, Vandenbosch R, Nguyen L, Malgrange B . Concise review: forkhead pathway in the control of adult neurogenesis. Stem Cells. 2014; 32(6):1398-407. DOI: 10.1002/stem.1673. View

15.

Lalmansingh A, Karmakar S, Jin Y, Nagaich A . Multiple modes of chromatin remodeling by Forkhead box proteins. Biochim Biophys Acta. 2012; 1819(7):707-15. DOI: 10.1016/j.bbagrm.2012.02.018. View

16.

Xu M, Chen X, Chen D, Yu B, Huang Z . FoxO1: a novel insight into its molecular mechanisms in the regulation of skeletal muscle differentiation and fiber type specification. Oncotarget. 2016; 8(6):10662-10674. PMC: 5354690. DOI: 10.18632/oncotarget.12891. View

17.

Murtaza G, Khan A, Rashid R, Muneer S, Hasan S, Chen J . FOXO Transcriptional Factors and Long-Term Living. Oxid Med Cell Longev. 2017; 2017:3494289. PMC: 5574317. DOI: 10.1155/2017/3494289. View

18.

Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M . Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A. 2004; 101(27):10042-7. PMC: 454161. DOI: 10.1073/pnas.0400593101. View

19.

Gonzalez F, Sia C, Shepard M, Rote N, Minium J . Inflammation in response to glucose ingestion is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2012; 97(11):4071-9. PMC: 3485595. DOI: 10.1210/jc.2012-2131. View

20.

Hosaka T, Biggs 3rd W, Tieu D, Boyer A, Varki N, Cavenee W . Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A. 2004; 101(9):2975-80. PMC: 365730. DOI: 10.1073/pnas.0400093101. View